Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

PARICALCITOL vs PAZOPANIB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

PARICALCITOL vs PAZOPANIB: Safety Overview

Metric PARICALCITOL PAZOPANIB
Total FAERS Reports 6,665 21,208
Deaths Reported 4,801 5,612
Death Rate 72.0% 26.5%
Hospitalizations 1,662 4,347
Average Patient Age 57.8 yrs 61.2 yrs
% Female Patients 43.1% 41.2%
FDA Approval Date Apr 17, 1998 Apr 23, 2024
Manufacturer Aurobindo Pharma Limited Golden State Medical Supply, Inc.
Route ORAL ORAL
Marketing Status Prescription Prescription